Is this actionable now?

closed. Innovate UK competition with fixed rounds; 2026 round 1 is closed and no later actionable deadline was verified.

What burden and restrictions apply?

The reviewed official source pages do not state a complete current reporting obligation. The reviewed official source pages do not state complete current use-of-funds restrictions.

What evidence exists?

Biomedical Catalyst has supported UK health-product R&D across repeated rounds. Innovate UK publishes call-specific project bands and grant rates. The reviewed official corpus does not publish a comparable applicant denominator and selection rate.

Biomedical Catalyst

Project-specific grant share under the call's industrial research and experimental development rates; total project-cost band is set in each round. · Innovate UK / Medical Research Council

Biomedical Catalyst is a grant programme from Innovate UK / Medical Research Council for UK-registered SMEs and eligible research partners developing innovative healthcare products, technologies, or processes Current lifecycle: closed. Real economics: Project-specific grant share under the call's industrial research and experimental development rates; total project-cost band is set in each round..

Tier 3governmentukhealthgrant

Apply Official site Open in the live directory

Key facts

Funder	Innovate UK / Medical Research Council
Amount	Project-specific grant share under the call's industrial research and experimental development rates; total project-cost band is set in each round.
Decision time	Not stated on the programme page
Eligibility	UK-registered SMEs and eligible research partners developing innovative healthcare products, technologies, or processes
Restrictions	The reviewed official source pages do not state a complete current reporting obligation. The reviewed official source pages do not state complete current use-of-funds restrictions.
Status	unknown

Always confirm on the official page before applying — dates and terms change.

Application process

Confirm live scope and grant rate
Submit Innovate UK application and finances
Independent assessor scoring
Portfolio decision and due diligence
Grant offer and monitored project

Background

Innovate UK / Medical Research Council operates Biomedical Catalyst. This pass separates direct cash, repayable finance, credits, incentives and umbrella programs so later ranking does not compare unlike instruments. Biomedical Catalyst has supported UK health-product R&D across repeated rounds. Innovate UK publishes call-specific project bands and grant rates.

How the application really works

Confirm live scope and grant rate → Submit Innovate UK application and finances → Independent assessor scoring → Portfolio decision and due diligence → Grant offer and monitored project

Tips

Show direct fit with healthcare products.
Show direct fit with medical technology.
Show direct fit with diagnostics.
Show direct fit with therapeutics.
Show direct fit with digital health.

Watch out for

Current lifecycle is closed.
The reviewed official source pages do not state a complete current reporting obligation.
The reviewed official source pages do not state complete current use-of-funds restrictions.

Track record

Biomedical Catalyst has supported UK health-product R&D across repeated rounds.
Innovate UK publishes call-specific project bands and grant rates.

The reviewed official corpus does not publish a comparable applicant denominator and selection rate.

Frequently asked questions

Is this actionable now?: closed. Innovate UK competition with fixed rounds; 2026 round 1 is closed and no later actionable deadline was verified.
What is the real economic value?: Project-specific grant share under the call's industrial research and experimental development rates; total project-cost band is set in each round.
Who is eligible?: UK-registered SMEs and eligible research partners developing innovative healthcare products, technologies, or processes
How does selection work?: Confirm live scope and grant rate; Submit Innovate UK application and finances; Independent assessor scoring; Portfolio decision and due diligence; Grant offer and monitored project. Not stated on the programme page
What burden and restrictions apply?: The reviewed official source pages do not state a complete current reporting obligation. The reviewed official source pages do not state complete current use-of-funds restrictions.
What evidence exists?: Biomedical Catalyst has supported UK health-product R&D across repeated rounds. Innovate UK publishes call-specific project bands and grant rates. The reviewed official corpus does not publish a comparable applicant denominator and selection rate.

Sources

www.ukri.org/opportunity/biomedical-catalyst-2025-industry-led-rd-large-projects — Official 2026 lifecycle, economics and eligibility (checked 2026-08-10)
www.ukri.org/what-we-do/browse-our-areas-of-investment-and-support/biomedical-catalyst — Official program history and outcome context (checked 2026-08-10)